Biopharma Bucking Market Trends on Positive FDA Feedback
01 11월 2024 - 2:00AM
AllPennyStocks.com
This firm’s treatment for a disfiguring skin infection has
demonstrated safety and efficacy across multiple Phase 2 and Phase
3 studies, and shares are holding their own despite
today's...
To read the full story on AllPennyStocks.com, click
here.
Appili Therapeutics (TSX:APLI)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Appili Therapeutics (TSX:APLI)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024